ROS1: Rearrangements und AnalytikROS1: rearrangements and analytics

被引：0
|
作者：
Udo Siebolts
Sabine Merkelbach-Bruse
机构：
[1] Universität zu Köln,Institut für Pathologie, Medizinische Fakultät und Uniklinik Köln
来源：
Die Pathologie | 2023年 / 44卷 / 1期
关键词：
D O I：
10.1007/s00292-022-01162-5
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：50 / 52
页数：2
相关论文
共 50 条
  • [1] ROS1: Rearrangements und Analytik
    Siebolts, Udo
    Merkelbach-Bruse, Sabine
    PATHOLOGIE, 2023, 44 (01): : 50 - 52
  • [2] Alternative rearrangements—targeting ROS1 in NSCLC
    David Killock
    Nature Reviews Clinical Oncology, 2014, 11 (11) : 624 - 624
  • [3] Immunohistochemical detection of ROS1 is useful for identifying ROS1 rearrangements in lung cancers
    Yoshida, Akihiko
    Tsuta, Koji
    Wakai, Susumu
    Arai, Yasuhito
    Asamura, Hisao
    Shibata, Tatsuhiro
    Furuta, Koh
    Kohno, Takashi
    Kushima, Ryoji
    MODERN PATHOLOGY, 2014, 27 (05) : 711 - 720
  • [4] Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements
    Cha, Yoon Jin
    Lee, Jae Seok
    Kim, Hye Ryun
    Lim, Sun Min
    Cho, Byoung Chul
    Lee, Chang Young
    Shim, Hyo Sup
    PLOS ONE, 2014, 9 (07):
  • [5] ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1
    Fielder, Timothy
    Butler, Jordan
    Tierney, Geraldine
    Holmes, Mikaela
    Lam, Ki Yuk
    Satgunaseelan, Laveniya
    Colebatch, Andrew J.
    Mahar, Annabelle
    Gupta, Ruta
    O'Toole, Sandra
    Cooper, Wendy A.
    PATHOLOGY, 2022, 54 (04) : 399 - 403
  • [6] ROS1 Immunohistochemistry as a Screen for ROS1 Rearrangements in Lung Adenocarcinoma: Application in Clinical Practice
    Pal, Prodipto
    Hammerman, Peter
    Kwiatkowski, David J.
    Johnson, Bruce E.
    Sholl, Lynette M.
    MODERN PATHOLOGY, 2016, 29 : 478A - 478A
  • [7] ROS1 Immunohistochemistry as a Screen for ROS1 Rearrangements in Lung Adenocarcinoma: Application in Clinical Practice
    Pal, Prodipto
    Hammerman, Peter
    Kwiatkowski, David J.
    Johnson, Bruce E.
    Sholl, Lynette M.
    LABORATORY INVESTIGATION, 2016, 96 : 478A - 478A
  • [8] ROS1 rearrangements are uncommon in biliary tract cancers
    Mazzoni, Francesca
    Petreni, Paolo
    Vasile, Enrico
    Panebianco, Michele
    Casadei-Gardini, Andrea
    Negri, Francesca
    Lunghi, Alice
    Pillozzi, Serena
    Vivaldi, Caterina
    Gervasi, Erika
    Frassineti, Giovanni Luca
    Messerini, Luca
    Jocolle, Genny
    Bisagni, Alessandra
    Antonuzzo, Lorenzo
    Rossi, Giulio
    ONCOLOGY LETTERS, 2020, 20 (06)
  • [9] ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer
    Pietrantonio, Filippo
    Di Nicolantonio, Federica
    Schrock, Alexa B.
    Lee, Jeeyun
    Tejpar, Sabine
    Sartore-Bianchi, Andrea
    Hechtman, Jaclyn F.
    Christiansen, Jason
    Novara, Luca
    Tebbutt, Niall
    Fuca, Giovanni
    Antoniotti, Carlotta
    Kim, Seung Tae
    Murphy, Danielle
    Berenato, Rosa
    Morano, Federica
    Sun, James
    Min, Bosun
    Stephens, Philip J.
    Chen, Marissa
    Cremolini, Chiara
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (12):
  • [10] Detection of ALK and ROS1 rearrangements by immunocytochemistry on cytological samples
    Frankel, Diane
    Bourlard, Donatienne
    Garcia, Stephane
    Robaglia-Schlupp, Andree
    Peker, Emel
    Groliere, Adele
    Kaspi, Elise
    Roll, Patrice
    ANNALES DE PATHOLOGIE, 2019, 39 (03) : 227 - 236
12345